AQR Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,230
| Closed | -$3.97M | – | 2303 |
|
|
2020
Q3 | $3.97M | Sell |
75,230
-37,720
| -33% | -$2.33M | 0.01% | 842 |
|
|
2020
Q2 | $6.92M | Sell |
112,950
-20,752
| -16% | -$1.2M | 0.01% | 712 |
|
|
2020
Q1 | $7.56M | Sell |
133,702
-21,434
| -14% | -$1.22M | 0.01% | 689 |
|
|
2019
Q4 | $8.83M | Sell |
155,136
-6,081
| -4% | -$322K | 0.01% | 792 |
|
|
2019
Q3 | $8.63M | Buy |
161,217
+47,487
| +42% | +$2.76M | 0.01% | 801 |
|
|
2019
Q2 | $6.79M | Buy |
113,730
+52,147
| +85% | +$3.28M | 0.01% | 878 |
|
|
2019
Q1 | $3.84M | Buy |
61,583
+14,175
| +30% | +$938K | ﹤0.01% | 1075 |
|
|
2018
Q4 | $2.87M | Buy |
47,408
+3,681
| +8% | +$220K | ﹤0.01% | 1122 |
|
|
2018
Q3 | $2.56M | Sell |
43,727
-55,988
| -56% | -$2.86M | ﹤0.01% | 1290 |
|
|
2018
Q2 | $4.47M | Sell |
99,715
-14,661
| -13% | -$631K | ﹤0.01% | 1077 |
|
|
2018
Q1 | $5.07M | Sell |
114,376
-21,117
| -16% | -$887K | 0.01% | 995 |
|
|
2017
Q4 | $5.87M | Buy |
135,493
+18,626
| +16% | +$837K | 0.01% | 969 |
|
|
2017
Q3 | $5.44M | Buy |
116,867
+24,562
| +27% | +$1.18M | 0.01% | 989 |
|
|
2017
Q2 | $4.57M | Buy |
92,305
+18,146
| +24% | +$951K | 0.01% | 1048 |
|
|
2017
Q1 | $4.06M | Buy |
74,159
+19,437
| +36% | +$1.03M | 0.01% | 1100 |
|
|
2016
Q4 | $3.05M | Buy |
54,722
+7,090
| +15% | +$341K | ﹤0.01% | 1231 |
|
|
2016
Q3 | $2.17M | Buy |
47,632
+7,755
| +19% | +$311K | ﹤0.01% | 1377 |
|
|
2016
Q2 | $1.59M | Buy |
39,877
+2,771
| +7% | +$101K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $1.29M | Buy |
37,106
+3,856
| +12% | +$142K | ﹤0.01% | 1472 |
|
|
2015
Q4 | $1.43M | Sell |
33,250
-5,647
| -15% | -$283K | ﹤0.01% | 1419 |
|
|
2015
Q3 | $1.69M | Buy |
38,897
+9,845
| +34% | +$531K | ﹤0.01% | 1208 |
|
|
2015
Q2 | $1.5M | Buy |
29,052
+18,552
| +177% | +$791K | ﹤0.01% | 1318 |
|
|
2015
Q1 | $411K | Buy |
+10,500
| New | +$412K | ﹤0.01% | 1769 |
|
Other funds holding BSTC
AQR Capital Management's BSTC Position: Q4 2020 in Review
AQR Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 75,230 shares — an estimated $3.97M sold.
AQR Capital Management first reported a position in BSTC in Q1 2015 and held it in 23 quarters. The position peaked at $8.83M in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- AQR Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- AQR Capital Management sold 75,230 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $3.97M.
- AQR Capital Management first reported a position in BioSpecifics Technologies Corp. in Q1 2015 and held it in 23 quarters.
- AQR Capital Management's BioSpecifics Technologies Corp. position peaked at $8.83M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.